Liver Targeting of Daclatasvir via Tailoring Sterically Stabilized Bilosomes: Fabrication, Comparative In Vitro/In Vivo Appraisal and Biodistribution Studies

INTRODUCTION: Hepatitis C virus (HCV) is a significant public health concern that threatens millions of individuals worldwide. Daclatasvir (DAC) is a promising direct-acting antiviral approved for treating HCV infection around the world. The goal of this study was to encapsulate DAC into novel polye...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Nabarawi, Mohamed, Nafady, Mohamed, Elmenshawe, Shahira, Elkarmalawy, Marwa, Teaima, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455511/
https://www.ncbi.nlm.nih.gov/pubmed/34556987
http://dx.doi.org/10.2147/IJN.S319255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455511/
https://www.ncbi.nlm.nih.gov/pubmed/34556987
http://dx.doi.org/10.2147/IJN.S319255

Ejemplares similares